阿坝子胀的痛是什么原因(石家庄年人体检查什么) (今日更新中)

BEIJING, Oct. 13 (Xinhuanet) -- Tyrannosaurus rex dinosaur, the giant prehistoric predator, was even bigger and heavier than it was estimated previously, a new study found.The finding was contained in a study published Wednesday in the scientific journal PLoS ONE.Using three-dimension scanning and computer modeling, researchers analyzed five skeleton fossils of T. rex dinosaur, including "Sue", the largest and most complete T. rex specimen ever found.The analysis tipped the scale of "Sue" at 9 ton, some 30 percent more than it was expected."At their fastest, in their teenage years, they were putting on 11 pounds or 5 kilograms a day," said John Hutchinson of the Royal Veterinary College in London, who co-led the study.The larger body mass indicated the better agility and the stronger lower-leg muscles of the ancient monster, said the researcher."Sue" could have a top speed of about 10-25 miles per hour when it ran on the Great Plains of North America 67 million years ago, Hutchinson suggested.

BEIJING, Dec. 11 (Xinhua) -- China is faced with severe challenges in collecting enough blood plasma to produce medicines, Health Minister Chen Zhu said Sunday.Chen called on the public to join blood donation after donating blood plasma at the Beijing Red Cross Blood Center on Sunday, the fifth time since he took office in 2007.Blood plasma is needed to make blood products like prothrombin complex which is vital for hemophiliacs.The total volume of blood plasma collected last year was 4,180 tonnes, while the volume needed to produce enough medicines was 8,000 tonnes, said a statement from the ministry. The situation became even worse this year.Donations of blood plasma in China fell dramatically in recent years, as a result of safety concerns from donors and the government's efforts to regulate blood collection after contamination triggered HIV infection scandals.In an overhaul of plasma collection services in 2004, the ministry closed 262 donation centers, leaving only 138 in operation, resulting in the plasma donations falling at least one-third from 5,000 tonnes in 2003.Blood plasma are currently collected at 144 designed stations across the mainland. The stations, as requested by law, are all owned by major manufacturers of blood products.Chen promised to encourage qualified drug makers to set up more collection stations in the next five years.He also assured the public the safety of blood donation at authorized stations.

BEIJING, Jan. 24 (Xinhua) -- China's meteorological authority said Tuesday that the country's northern regions will continue to have sunny weather for the coming 24 hours, while the south will see subdued rain and snow.Temperatures in most parts of the country are expected to rebound slightly, the National Meteorological Center said in a statement on its website.But the lowest temperatures in the areas south of the Yangtze River will remain around zero degree Celsius, the center said.Meanwhile, rain and snow will subdue in most parts of the southern regions over the next three days, although freezing rain is forecast to hit Guizhou and Hunan provinces, according to the statement.

WASHINGTON, Oct. 6 (Xinhua) -- The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced Thursday a joint, large-scale, national study of tobacco users to monitor and assess the behavioral and health impacts of new government tobacco regulations.The initiative is the first large-scale NIH/FDA collaboration on tobacco regulatory research since the U.S. Congress granted FDA the authority to regulate tobacco products in an act in 2009. Scientists at NIH's National Institute on Drug Abuse and the FDA's Center for Tobacco Products will coordinate the effort."The launch of this study signals a major milestone in addressing one of the most significant public health burdens of the 21st century," said FDA Commissioner Margaret Hamburg in a statement. "The results will strengthen FDA's ability to fulfill our mission to make tobacco-related death and disease part of America's past and will further guide us in targeting the most effective actions to decrease the huge toll of tobacco use on our nation's health."Investigators will follow more than 40,000 users of tobacco- product and those at risk for tobacco use ages 12 and older. They will examine what makes people susceptible to tobacco use; evaluate use patterns and resulting health problems; study patterns of tobacco cessation and relapse in the era of tobacco regulation; evaluate the effects of regulatory changes on risk perceptions and other tobacco-related attitudes; and assess differences in attitudes, behaviors and key health outcomes in racial-ethnic, gender, and age subgroups."We are pleased to collaborate with the FDA on this study that may provide us with a better understanding of the impact of product regulation on tobacco prevention and cessation," said NIH Director Francis Collins.While smoking rates have dropped significantly since their peak in the 1960s, nearly 70 million Americans ages 12 and older were current users of tobacco products in 2010. As a result, death and disease caused by tobacco use is still a tremendous public health burden. Tobacco use is the leading preventable cause of disease, disability, and death in the United States. Cigarette smoking results in more than 443,000 premature deaths in the United States each year -- more than alcohol, illegal drug use, homicide, suicide, car accidents, and AIDS combined.

WASHINGTON, Oct. 9 (Xinhua) -- U.S. researchers have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication Sunday in Nature Biotechnology, researchers describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage."The white blood cells known as monocytes play a critical role in the early stages of the immune response," says Matthias Nahrendorf, of the Massachusetts General Hospital (MGH) Center for Systems Biology, the paper's senior author. "We now know there are two subsets of monocytes -- an inflammatory subset that defends against pathogens and a reparative subset that supports healing. But if the inflammatory response is excessive, it can block the healing process and exacerbate conditions such as heart disease and cancer."Cells damaged by injury or disease release a cocktail of chemicals called cytokines that attract immune cells to the site of the damage. Inflammatory monocytes are guided to sites of tissue injury by a receptor protein called CCR2, and the MGH-led team devised a strategy targeting that molecule to block the inflammatory process but not the action of the reparative monocytes.Small interfering RNA (siRNA) technology prevents production of specific proteins by binding to associated messenger RNA molecules and preventing their translation. However, the technique requires extreme precision in developing the right siRNA molecule and delivering it to the correct cellular location.To make sure that their siRNA preparation targeted the right monocytes, researchers first confirmed that its use reduced levels of CCR2 in monocytes and increased levels of the fragments produced when siRNA binds to its target. They then showed that monocytes from mice treated with the siRNA preparation were unable to migrate towards CCR2's usual molecular target. Experiments in animal models of several important diseases showed that the siRNA preparation reduced the amount of cardiac muscle damaged by a heart attack, reduced the size and the number of inflammatory cells in atherosclerotic plaques and in lymphomas, and improved the survival of transplanted pancreatic islets."These inflammatory monocytes are involved in almost every major disease," Nahrendorf explains. "Anti-inflammatory drugs currently on the market hit every inflammatory cell in the body, which can produce unwanted side effects. This new siRNA treatment doesn't affect inflammatory cells that don't rely on the CCR2 receptor. That makes a big difference."

来源：资阳报